VacZine Analytics releases MarketVIEW: Cocaine dependence vaccines


Today UK-based strategic research consultancy VacZine Analytics releases a new commercial market forecast for cocaine dependence vaccines.

MarketVIEW: Cocaine dependence vaccines is a comprehensive commercial opportunity assessment detailing the potential market for a cocaine dependence vaccine with a patient based value/volume forecast for the major seven markets to 2030. Two target product profiles (TPP) are forecasted with differing efficacy levels/administration profiles. The analysis also gives an up-to-date review of worldwide epidemiology/guidelines/classifications and an overview of current research and development in the field.


To read more information, click here.

VacZine Analytics is an established strategic research publisher based in the United Kingdom.

VacZine Analytics Ltd (Assay Advantage)